Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00549107Phase 2Unknown
A Phase 2 trial of levosimendan in low cardiac output syndrome (LCOS), sponsored by Ludwig Boltzmann Gesellschaft. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00549107.